Retina Vitreous Center

What Retina Vitreous Center does

Retina Vitreous Center (RVC) is a private ophthalmology specialty practice headquartered in Edmond, Oklahoma, providing medical and surgical care for retinal and vitreous disorders, uveitis, and ocular oncology. The practice is staffed by six fellowship-trained retina subspecialty ophthalmologists — including rare uveitis and ocular oncology specialists — along with an optometrist and a vitreoretinal disease fellow, and operates six clinic locations spanning Edmond/North Oklahoma City, Norman, Midwest City, Stillwater, Elk City, and Lawton. Services span intravitreal injections, retinal laser treatment, vitrectomy surgery (including 25g sutureless technique), and management of conditions such as age-related macular degeneration, diabetic retinopathy, retinal detachments, macular holes, epiretinal membranes, retinal vein occlusions, uveitis, and choroidal melanoma.

The practice is the only center in Oklahoma for both ocular oncology and uveitis and was the first in the state to perform gene therapy for wet age-related macular degeneration and to place sustained release drug delivery devices. RVC is the first and only retinal private practice in Oklahoma participating in the NIH/NEI-sponsored Diabetic Retinopathy Clinical Research Network and runs what it describes as the state's most active clinical trials program in retina, uveitis, and ocular oncology, including multiple Phase 3 FDA registration studies and industry-sponsored trials. Diagnostic capability is anchored in state-of-the-art OCT and fluorescein angiography equipment.

The business model is fee-for-service clinical ophthalmology, accepting most major PPO insurance plans with co-pays collected at time of service and self-pay patients paying in full. A secondary revenue stream derives from sponsored clinical research participation. Go-to-market is primarily referral-driven from ophthalmologists, optometrists, and primary care physicians across Oklahoma, supplemented by self-referrals, second opinions, and clinical-trial enrollment. The practice is independently physician-owned, with no disclosed external investment, private equity backing, or parent company.

Name

Retina Vitreous Center

Legal name

Retina Vitreous Center

Website

https://rvcoklahoma.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Retina Vitreous Center is a private Oklahoma ophthalmology practice operating six locations and staffed by six fellowship-trained retina specialists delivering medical, surgical, and clinical-trial care for retinal, vitreous, uveitis, and ocular oncology patients statewide.

Ownership category

akta.pro rank

Product category

Specialty Ophthalmology (Retina and Vitreous Care)

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industries

Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN), Ophthalmology Gene Therapies (HLAAACAG)

Keywords

• Retina ophthalmology care
• Vitreoretinal surgery
• Macular degeneration treatment
• Diabetic retinopathy care
• Ocular oncology services

Headquarters

HQ city

Edmond

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Ophthalmology Services: Fee-for-service medical practice providing specialized retina and vitreous care. Accepts most major PPO insurance plans. Co-payments due at time of service. Self-pay patients responsible for full payment at time of service.
2. Clinical Research: Participates in NIH/NEI sponsored clinical trials and industry-sponsored Phase 3 FDA registration trials. Provides patients access to novel treatments.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Retina Vitreous Center provides medical and surgical diagnosis and treatment for retinal and vitreous disorders, including age-related macular degeneration, diabetic retinopathy, retinal detachment and tears, epiretinal membranes, macular holes, uveitis, and ocular oncology (choroidal melanoma). The practice also operates an active clinical research program participating in NIH/NEI and industry-sponsored Phase 3 FDA registration trials, offering patients access to novel therapies including gene therapy for wet AMD.

Product overview

Retina Vitreous Center is Oklahoma's largest and most comprehensive retina practice offering a unified suite of medical and surgical retina care services. The practice operates as a single integrated healthcare delivery system centered around six fellowship-trained retina subspecialty ophthalmologists and an ocular disease residency-trained optometrist. Core services include treatments for age-related macular degeneration, diabetic eye disease, detached/torn retina, epiretinal membranes, macular holes, and uveitis. The practice also offers specialized ocular oncology services and maintains an active clinical trials program as part of the NIH/NEI sponsored DRCR Retina Network. Treatment modalities include intravitreal injections, laser treatment, and vitrectomy surgery. The practice has achieved notable firsts including performing Oklahoma's first gene therapy for wet age-related macular degeneration and first sustained release device placement.

Differentiator

Problem solved

Functional benefit

Products and services

• Age-Related Macular Degeneration Treatment Treatment service for age-related macular degeneration (AMD) using anti-VEGF intravitreal injections (Avastin, Lucentis, Eylea) for wet AMD and AREDS2 vitamin supplementation for dry AMD, offered to patients with AMD referred to RVC.
• Detached or Torn Retina Treatment Surgical repair service for retinal detachments and tears using pneumatic retinopexy, scleral buckle procedure, and vitrectomy surgery with laser or cryotherapy, for patients with detached or torn retina.
• Diabetic Eye Disease Treatment Comprehensive treatment service for diabetic eye disease including laser surgery, intraocular injections to suppress retinal swelling and abnormal blood vessel growth, and vitrectomy for diabetic retinopathy, for patients with diabetic eye complications.
• Epiretinal Membrane / Macular Pucker Treatment Vitrectomy surgery service with membrane peeling to remove scar tissue growing over the macula using a 25g sutureless technique, for patients with epiretinal membranes (macular pucker).
• Intravitreal Injections Intravitreal injection service delivering medication into the vitreous gel to treat retinal vein occlusion, macular degeneration, swelling, infections, and macular edema, for patients with qualifying retinal conditions.
• Laser Treatment Retinal laser treatment service for diabetic retinopathy, retinal vein occlusions, retinal tears, macular holes, glaucoma, macular degeneration, and ocular tumors, for patients requiring targeted laser intervention.
• Vitrectomy Surgery Vitrectomy surgery service using small gauge sutureless technique to treat disorders of the retina and vitreous, including retinal detachments, diabetic retinopathy, macular holes, and trauma, for patients requiring vitreoretinal surgery.
• Macular Hole Treatment Vitrectomy surgery service with membrane peeling and internal limiting membrane removal to treat macular holes, for patients diagnosed with macular hole.
• Clinical Trials Program Clinical research service participating in NIH/NEI-sponsored trials and industry-sponsored Phase 3 FDA registration studies, including trials for geographic atrophy, wet AMD, diabetic macular edema, and gene therapy, providing patients access to novel treatments through the DRCR Retina Network.
• Ocular Oncology and Uveitis Specialty Services Specialty ophthalmology services providing management of ocular surface and intraocular tumors including choroidal melanoma and treatment of uveitis (inflammation of the eye) including infectious uveitis and posterior non-infectious uveitis, offered as Oklahoma's only center for ocular oncology and uveitis.

Quantifiable outcome

• Nationally recognized for receiving Quality Research Award by DRCR Retina Network for 2015, 2017, 2018, and 2020
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• DRCR Retina Network (Diabetic Retinopathy Clinical Research Network)coreStrategic or Co-development PartnerParticipating site in the DRCR Retina Network, formed in September 2002 and funded by the National Eye Institute (NEI), part of the National Institutes of Health. Includes over 115 participating sites with over 400 physicians throughout the United States. Retina Vitreous Center has been nationally recognized for receiving Quality Research Awards in 2015, 2017, 2018, and 2020. RVC physicians have contributed to multiple studies published in NEJM, JAMA, and Ophthalmology.
• National Eye Institute (NEI) / National Institutes of Health (NIH)coreStrategic or Co-development PartnerParticipating in NIH and NEI-sponsored clinical trials since 2013. First and only retinal private practice in Oklahoma as part of NIH/NEI sponsored Diabetic Retinopathy Clinical Research Network.
• Summit Medical CentercoreStrategic or Co-development PartnerSurgical facility where Dr. Shah primarily operates. Located in Edmond, OK. Provides operating room setting for vitrectomy and other retina surgeries.
• Oklahoma SurgicarecoreStrategic or Co-development PartnerSurgical center where Dr. Shah primarily operates. Located in Oklahoma City, OK. Provides outpatient surgical facilities for retina procedures.
• Integris Baptist Medical CenterminorStrategic or Co-development PartnerDr. Shah holds staff privileges at this Oklahoma City hospital for surgical procedures.
• Mercy Hospital Oklahoma CityminorStrategic or Co-development PartnerSurgical privileges for retina procedures at Mercy Hospital in Oklahoma City.
• St. Anthony HospitalminorStrategic or Co-development PartnerUsed specifically for plaque procedures for choroidal melanoma treatment.
• Bascom Palmer Eye InstituteminorStrategic or Co-development PartnerDr. Grasic completed J-1 Ophthalmology Medical Retina Fellowship program at University of Miami/Bascom Palmer Eye Institute. Dr. Elnahry received fellowship training from Bascom Palmer Eye Institute.
• National Eye Institute / National Institutes of HealthcoreStrategic or Co-development PartnerDr. Grasic completed Ophthalmology-Uveitis Fellowship with the National Eye Institute/NIH. Dr. Elnahry also received fellowship training from the National Eye Institute.
• Referring Physicians NetworkcoreChannel Partner/ Reseller/ DistributorNetwork of ophthalmologists, optometrists, and primary care physicians across Oklahoma who refer patients to RVC. Practice emphasizes open communication and keeps referring physicians updated regarding mutual patients.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Dean McGee Eye Institute: Oklahoma-based academic eye institute located in Oklahoma City offering a broader range of ophthalmology subspecialties including retina care; relevant as an in-state incumbent that competes for retina referrals in the same geography as RVC.

Direct peers

• California Retina Consultants: Multi-site California retina practice with significant clinical research activity and fellowship-trained physicians; directly comparable as a large retina subspecialty group combining patient care and trial enrollment.
• Retina Associates of Florida: Large multi-physician retina subspecialty practice in Florida offering medical and surgical retinal care with an active clinical trials program; comparable in structure, subspecialty depth, and clinical-research positioning to Retina Vitreous Center.
• Tennessee Retina: Multi-location Tennessee retina subspecialty group with active clinical research program; directly comparable as a regional multi-physician retina practice combining clinical trials and surgical care.
• Retina Group of Florida: Florida-based multi-location retina subspecialty practice with surgical and clinical trial offerings; comparable in geographic-coverage model (multiple satellite clinics) and subspecialty depth.
• Retina Consultants of Texas: Multi-location Texas-based retina specialty group with deep clinical trials involvement and a similar fellowship-trained physician model; directly comparable as a large independent retina practice combining clinical care and research.
• Mid-Atlantic Retina: Pennsylvania-based retina subspecialty practice with multiple physicians and clinical trial participation; comparable in service mix (vitreoretinal surgery, AMD, diabetic retinopathy) and academic affiliations.
• Vitreoretinal Consultants: New York-based multi-physician vitreoretinal specialty practice offering medical and surgical retina care; comparable in scope of subspecialty services and physician training pedigree.
• Long Island Vitreoretinal Consultants: New York-based multi-physician retina specialty practice offering surgical and medical vitreoretinal care; comparable in service offerings and physician-subspecialist structure.
• New England Retina Associates: Multi-physician New England retina specialty practice providing medical and surgical vitreoretinal care; comparable as a fellowship-trained subspecialty group with active clinical research.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/rvcoklahoma
• LinkedInlinkedin.com/company/rvcoklahoma

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina Vitreous Center